The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain

被引:47
|
作者
Lee, Hae-Jin
Pogatzki-Zahn, Esther M.
Brennan, Timothy J.
机构
[1] Univ Iowa, Dept Anesthesia, Coll Med, Iowa City, IA 52242 USA
[2] Univ Munster, Klin & Poliklin Anesthesiol & Operat Intens Med, D-4400 Munster, Germany
来源
JOURNAL OF PAIN | 2006年 / 7卷 / 10期
关键词
glutamate; incision; nonNMDA; hyperalgesia;
D O I
10.1016/j.jpain.2006.03.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Non-N-methyl-D-aspartate (non-NMDA) glutamate receptor antagonists modify multiple pain transmission pathways and are of particular interest in analgesic development because of their capacity to interfere with evoked pain. Evoked pain is a problem for postoperative patients and is characteristic of the plantar incision model for postoperative pain. The purpose of this study was to assess the efficacy of a non-NMDA receptor antagonist LY293558 on mechanical hyperalgesia after plantar incision in the rat. Parenteral, intrathecal, or intraplantar administration of LY293558 was tested against the mechanical hyperalgesia that characterizes the model. Sprague-Dawley rats were assigned to 1 of 3 groups. LY293558 or vehicle was administered intraperitoneally, intrathecally, or intraplantarly. The hind paw withdrawal threshold to punctate stimulation by using von Frey filaments and response frequency to a nonpunctate stimulus directly to the wound were measured. Motor tests after administration of LY293558 were also examined in rats that did not undergo incision. The greatest dose of parenterally administered LY293558 (34 mu mol/kg) decreased the responses to mechanical stimuli after plantar incision. Rotorod performance was decreased at these same times. Intrathecal injection of LY293558 (0.5 and 2.0 nmol) produced inhibition of mechanical sensitivity and produced lower extremity motor side effects. Repeated intrathecal administration produced sustained anesthesia for 24 hours but had no analgesic effect the next day. Local administration did not decrease response after incision. LY293558 was most effective for evoked pain when administered intrathecally. Perspective: Control of evoked pain after surgery is inadequate but is linked to perioperative outcome. These data suggest that non-NMDA receptor antagonists like LY293558 will be most effective for evoked pain in postoperative patients if administered spinally. (c) 2006 by the American Pain Society
引用
收藏
页码:768 / 777
页数:10
相关论文
共 50 条
  • [1] Effect of systemic and intrathecal AMPA-kainate receptor antagonist LY 293558 in a rat model for post operative pain
    Brennan, TJ
    Lee, HJ
    Pogatzki, EM
    ANESTHESIOLOGY, 1999, 91 (3A) : U407 - U407
  • [2] CHARACTERIZATION OF LY293558 AS A STEREOSELECTIVE AND COMPETITIVE AMPA RECEPTOR ANTAGONIST ON RAT NEOCORTICAL SLICES
    LODGE, D
    PALMER, AJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 : P17 - P17
  • [3] AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans
    Sang, CN
    Hostetter, MP
    Gracely, RH
    Chappell, AS
    Schoepp, DD
    Lee, G
    Whitcup, S
    Caruso, R
    Max, MB
    ANESTHESIOLOGY, 1998, 89 (05) : 1060 - 1067
  • [4] No Neuropathology Associated With Acute or Subchronic Treatment With the Selective AMPA/Kainate Antagonist Tezampanel (LY293558)
    Baskin, P.
    Reno, F.
    Graham, E.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 (01) : 62 - 63
  • [5] Safety and analgesic efficacy of the AMPA/kainate antagonist LY293558 following oral surgery.
    Gilron, I
    Max, MB
    Lee, G
    Booher, SL
    Dionne, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 93 - 93
  • [6] The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence
    McLemore, GL
    Kest, B
    Inturrisi, CE
    BRAIN RESEARCH, 1997, 778 (01) : 120 - 126
  • [7] The competitive AMPA antagonist, LY293558, as a neuroprotective agent in the CNS.
    Ornstein, PL
    Arnold, MB
    Augenstein, NK
    Schoepp, DD
    Leander, JD
    Lodge, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 106 - MEDI
  • [8] STEREOSPECIFIC EFFECTS OF THE COMPETITIVE AND SELECTIVE AMPA ANTAGONIST LY293558 ON RAT SPINAL NEURONS IN-VIVO
    BOND, A
    LODGE, D
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 : P109 - P109
  • [9] AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine
    Carlezon, WA
    Rasmussen, K
    Nestler, EJ
    SYNAPSE, 1999, 31 (04) : 256 - 262
  • [10] AMPA ANTAGONIST LY293558 DOES NOT AFFECT THE SEVERITY OF HYPOXIC-ISCHEMIC BRAIN INJURY
    LEBLANC, MH
    LI, XQ
    HUANG, M
    PATEL, DM
    SMITH, EE
    PEDIATRIC RESEARCH, 1995, 37 (04) : A382 - A382